Cancer test kit DROPLEX BRAF
for genetic mutationsfor thyroid diseasesblood

cancer test kit
cancer test kit
cancer test kit
Add to favorites
Compare this product
 

Characteristics

Applications
for cancers, for genetic mutations, for thyroid diseases
Sample type
blood, FFPE tissues, for DNA
Analysis mode
for PCR
Other characteristics
digital

Description

* IVD for PTC (papillary thyroid cancer) patients. * ddPCR-based detection for 5 BRAF mutations in Exon 15 from FFPE tissue sample * 2 Well-reactions/Test (24 Tests/Kit); 5 hrs for 22 Tests * Cat. No. GCXD0301 These tests detect DNA mutations by analyzing certain genes extracted from the patient's blood and tumor samples based on ddPCR platform which is optimized for companion diagnostics. They select patients who benefit the effectiveness of cancer treatment. Compared to traditional biopsy for gene mutation detection, blood samples require more sensitive testing because of their low DNA extraction. Digital PCR technology, ddPCR*, is a advanced platform specialized in liquid biopsy samples because it can detect mutations accurately even with a small amount of DNA.

Catalogs

No catalogs are available for this product.

See all of Gencurix‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.